Engineering Bacteria for Environmental Release: Regulatory Challenges and Design Strategies

preprint OA: closed
View at publisher
AI-generated summary by claude@2026-07, 2026-07-05

This paper examines the regulatory hurdles and design considerations for genetically engineered bacteria intended for environmental release.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Promising many societal benefits, emergent products of biotechnology involve releasing genetically modified microbes (GMMs) into the environment. However, regulatory challenges limit their use. So far, GMMs have mainly been tested in agriculture and environmental cleanup, with few approved for commercial purposes. Current government regulations inadequately address modern genetic engineering and limit the potential of gut therapeutics, skin products, self-repairing materials, ocean pollution treatment, anti-corrosion coatings, etc. This review first describes current U.S. regulations for engineered bacterial release. We analyze 57 global studies on soil-released GMMs and laboratory microcosm experiments. We discuss the environmental behavior of released bacteria and offer engineering guidelines to improve performance, control persistence, and reduce risk. Advanced technologies that improve GMM function and control, but lead to increases regulatory scrutiny, are reviewed. Finally, we propose a new regulatory framework informed by recent data to maximize the benefits of GMMs and rapidly address risks.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00